86 related articles for article (PubMed ID: 21717885)
21. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
[TBL] [Abstract][Full Text] [Related]
22. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
23. HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.
Jaafar A; Massip P; Sandres-Sauné K; Souyris C; Pasquier C; Aquilina C; Izopet J
J Med Virol; 2004 Sep; 74(1):8-15. PubMed ID: 15258962
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
Collazos J; Asensi V; Cartón JA
AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038
[TBL] [Abstract][Full Text] [Related]
25. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.
Le Moing V; Thiébaut R; Chêne G; Sobel A; Massip P; Collin F; Meyohas M; Al Kaïed F; Leport C; Raffi F;
HIV Med; 2007 Apr; 8(3):156-63. PubMed ID: 17461859
[TBL] [Abstract][Full Text] [Related]
26. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
27. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
Galli M; Balotta C; Meroni L; Colombo MC; Papagno L; Bagnarelli P; Testa L; Varchetta S; Colombo L; Moroni M; d'Arminio Monforte A; Clerici M; Clementi M
AIDS; 1998 Dec; 12(18):2500-2. PubMed ID: 9875591
[No Abstract] [Full Text] [Related]
28. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
29. IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort.
Fontas E; Kousignian I; Pradier C; Poizot-Martin I; Durier C; Weiss L; Levy Y; Costagliola D; ;
J Antimicrob Chemother; 2010 Oct; 65(10):2215-23. PubMed ID: 20702463
[TBL] [Abstract][Full Text] [Related]
30. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
[TBL] [Abstract][Full Text] [Related]
31. Effects of Radiation Therapy on Immunological and Virological Status in HIV-Infected Cancer Patients in Thailand: A Multicenter Prospective Study.
Siraprapasiri P; Tharavichitkul E; Suntornpong N; Tovanabutra C; Meennuch E; Panboon P; Swangsilpa T; Siraprapasiri T
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S9-16. PubMed ID: 27266211
[TBL] [Abstract][Full Text] [Related]
32. A case of severe thrombocytopaenia associated with acute HIV-1 infection.
Aoki A; Moro H; Watanabe T; Asakawa K; Miura S; Moriyama M; Tanabe Y; Kagamu H; Narita I
Int J STD AIDS; 2015 Mar; 26(3):209-11. PubMed ID: 24737880
[TBL] [Abstract][Full Text] [Related]
33. Current perspectives in HIV therapeutics.
Okulicz JF
Ann Allergy Asthma Immunol; 2011 Jul; 107(1):12-3. PubMed ID: 21704879
[No Abstract] [Full Text] [Related]
34. Initiating antiretroviral therapy during HIV infection: confusion and clarity.
Pomerantz RJ
JAMA; 2001 Nov; 286(20):2597-9. PubMed ID: 11722276
[No Abstract] [Full Text] [Related]
35. Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy.
Maggiolo F; Bottura P; Capra R; Pirali A; Zaffaroni P; Suter F
AIDS; 1999 Aug; 13(12):1594-5. PubMed ID: 10465093
[No Abstract] [Full Text] [Related]
36. Bariatric surgery: An HIV-positive patient's successful journey.
Eddy F; Elvin S; Sanmani L
Int J STD AIDS; 2016 Jan; 27(1):70-1. PubMed ID: 25663245
[TBL] [Abstract][Full Text] [Related]
37. Women have a greater immunological response to effective virological HIV-1 therapy.
Finkel DG; John G; Holland B; Slim J; Smith SM
AIDS; 2003 Sep; 17(13):2009-11. PubMed ID: 12960846
[No Abstract] [Full Text] [Related]
38. Association between alcohol use and HIV viral load.
Wu ES; Metzger DS; Lynch KG; Douglas SD
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):e129-30. PubMed ID: 21532918
[No Abstract] [Full Text] [Related]
39. Research letter: is monitoring for CD4 counts still needed for the management of patients with long-term HIV RNA suppression?
Stephan C; Hill A; Xi N; van Delft Y; Moecklinghoff C
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):e73-5. PubMed ID: 23183153
[No Abstract] [Full Text] [Related]
40. True gynaecomastia, another manifestation of immune reconstitution disease?
Qazi NA; Morlese JF; King DM; Ahmad RS; Gazzard BG; Nelson MR
Int J STD AIDS; 2002 Jan; 13(1):59-65. PubMed ID: 11802933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
